Darunavir and Plavix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Darunavir and Plavix. Common interactions include lactic acidosis among females and cardio-respiratory arrest among males.

The phase IV clinical study analyzes what interactions people who take Darunavir and Plavix have. It is created by eHealthMe based on reports of 10 people who take Darunavir and Plavix from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jun, 09, 2022

10 people who take Darunavir and Plavix together, and have interactions are studied.


What is Darunavir?

Darunavir has active ingredients of darunavir. eHealthMe is studying from 4,729 Darunavir users for its effectiveness, alternative drugs and more.

What is Plavix?

Plavix has active ingredients of clopidogrel bisulfate. It is often used in blood clots. eHealthMe is studying from 141,085 Plavix users for its effectiveness, alternative drugs and more.

Number of Darunavir and Plavix reports submitted per year:

Darunavir and Plavix drug interactions.

Common Darunavir and Plavix drug interactions by gender *:

female:

  1. Lactic acidosis

male:

  1. Cardio-respiratory arrest
  2. Dermatitis exfoliative
  3. Hypovolaemic shock
  4. Lower gastrointestinal haemorrhage
  5. Anal cancer recurrent
  6. Arterial stent insertion
  7. Constipation
  8. Femoral artery occlusion
  9. Gastrointestinal stoma necrosis
  10. Pseudomonal sepsis

Common Darunavir and Plavix drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Coronary arterial stent insertion
  2. Hypovolaemic shock
  3. Lower gastrointestinal haemorrhage

50-59:

  1. Cardio-respiratory arrest
  2. Dermatitis exfoliative
  3. Arterial stent insertion
  4. Constipation
  5. Femoral artery occlusion
  6. Gastrointestinal stoma necrosis
  7. Lactic acidosis
  8. Pseudomonal sepsis
  9. Respiratory disorder
  10. Septic shock

60+:

n/a

Common conditions people have *:

  1. Hiv Infection: 8 people, 80.00%
  2. High Blood Cholesterol: 2 people, 20.00%
  3. High Blood Pressure: 1 person, 10.00%
  4. Haematochezia (passage of stools containing blood): 1 person, 10.00%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 10.00%
  6. Fungal Nail Infection: 1 person, 10.00%
  7. Erection Problems: 1 person, 10.00%
  8. Dyslipidaemia (abnormal amount of lipids): 1 person, 10.00%
  9. Diarrhea: 1 person, 10.00%
  10. Weight Increased: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Darunavir and Plavix?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Darunavir and Plavix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Darunavir interactions:

Browse all interactions between Darunavir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Plavix interactions:

Browse all interactions between Plavix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on darunavir and clopidogrel bisulfate (the active ingredients of Darunavir and Plavix, respectively), and Darunavir and Plavix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Darunavir and Plavix.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: